Navigation Links
For the first time, researchers identify and isolate adult mammary stem cells in mice
Date:8/30/2010

SEATTLE For the first time, researchers at Fred Hutchinson Cancer Research Center have identified and isolated adult mammary stem cells in mice. Long-term implications of this research may include the use of such cells to regenerate breast tissue, provide a better understanding of the role of adult stem cells in breast cancer development, and develop potential new targets for anti-cancer drugs.

The findings, by Larry Rohrschneider, Ph.D., a member of the Basic Sciences Division at the Hutchinson Center, and Lixia Bai, M.D., Ph.D., a research associate in his lab, are published in the Sept. 1 issue of Genes & Development.

Using a genetically modified mouse model, the researchers tagged stem cells with green fluorescent protein (GFP), which exhibits bright green fluorescence during gene expression and can be easily seen under a microscope. GFP expression is controlled by the promoter of a newly identified gene, specifically expressed in stem cells, called s-SHIP.

Until now, we have not been able to identify stem cells in mammary tissue. They have never been detected before with such specificity. It is extraordinary. You can see these green stem cells under the microscope in their pure, natural state, said Rohrschneider, who has filed a patent on the s-SHIP promoter-GFP-labeling technology.

Previous systems for isolating stem cells have relied on a variety of biomarkers, none of which have yielded a pure stem cell population. This limitation has prohibited accurate gene-expression analysis of such cells.

The researchers demonstrated the presence of active green stem cells at crucial stages of mammary development, such as puberty and pregnancy. During quiescent stages of development, however, the cells did not "light up."

Such stem cells represent a new alternative to induced pluripotent stem cells, or genetically altered stem cells, for various medical applications.

For example, by isolating the pure green mammary cells from donor female transgenic mice, the researchers have demonstrated the regenerative ability of these cells by transplanting them into the mammary fat tissue of recipient mice whose own mammary epithelium has been removed.

"We have found that those transplanted green stem cells can generate new mammary tissue and this tissue can produce milk, just like normal mammary epithelial cells," said co-author Bai. "Identification of the exact stem cell and its location is the first critical and fundamental step toward understanding the regulatory mechanisms of these important cells."

In addition to potential clinical applications regarding tissue regeneration, the researchers see these isolated stem cells as a window to better understanding how normal stem cells can become cancer stem cells, which are hypothesized to exist in tumors.

"Our belief right now is that perhaps the most aggressive tumors may be coming from the malignant transformation of stem cells in healthy tissue," Rohrschneider said. "This new technology offers a unified model for identifying normal and cancer stem cells."

Cancer stem cells are thought to be responsible for tumor initiation, growth, metastasis, therapy resistance and disease relapse.

"Because stem cells are critical for both normal tissue development and cancer development, exploring how they are regulated in normal development will help us to better understand how they are transformed into breast cancer cells," Bai said. "By searching for new methods to effectively and specifically target cancer stem cells, we hope we can cure breast cancer someday." she said.


'/>"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related medicine news :

1. Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
2. Southampton to conduct UKs first cochlear implant operation to give sound in both ears
3. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
4. K-State professors book is first to explore Two-Spirit literature in Northwest native groups
5. Deaf, hard-of-hearing students perform first test of sign language by cell phone
6. CRF announces late breaking trials and first report investigations to be presented at TCT 2010
7. Doctors hard to find for patients in Massachusetts first for-profit health plan
8. Scientists develop the first model for investigating the origins of testicular cancer in humans
9. UCLA scientists for the first time identify a cell-of-origin for human prostate cancer
10. Why the MRC didnt fund research that led to the birth of the worlds first test tube baby
11. UCLA scientists isolate the first stages of tissue production in human embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or ... But how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional ... early symptoms of AMD? A study published recently in Dove Medical Press ...
(Date:6/23/2017)... ... June 23, 2017 , ... Everybody has their own personal preference when it ... it, and some people don't like it at all. FindaTopDoc took a look at ... Erotic literature can give readers a taste of their deepest, darkest fantasies and has ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State University will ... 20. , The two-day conference is focused on advancing scientific knowledge about the ... lives and eliminating racial breast cancer-related disparities. The conference theme is “Illuminating Actionable ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Private Flood Insurance offerings. With the Federal Emergency Management Agency’s (FEMA) recent update ... the United States. In 2012, the Biggert-Waters Act was enacted to reflect the ...
Breaking Medicine News(10 mins):
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... 2017 Therapix Biosciences Ltd. (Nasdaq: TRPX), ... the development of cannabinoid-based drugs, today announced that ... at three upcoming scientific and investor conferences in ... Invitational: ...                     Wednesday, June ...
(Date:5/23/2017)...  Leaf Healthcare, recognized for developing one of ... ulcer prevention, will unveil its comprehensive mobility monitoring ... Nurses, National Teaching Institute and Critical Care Exposition ... Patient Monitoring System is the first mobility monitoring ... system seamlessly tracks patient movement throughout the mobility ...
Breaking Medicine Technology: